The type I IFN family has the broadest range of biological effects and is most widely studied in oncology; IFNα (encoded by 13 genes) and IFNβ (single gene) are the predominant subtypes [11]; IFNα, in particular, has been extensively studied for its anti-tumor activity against several malignancies [2]. Here, IFNA17 is linked to neoplasm.